Literature DB >> 135262

Congenic strains of mice susceptible and resistant to mouse hepatitis virus.

W Weiser, I Vellisto, F B Bang.   

Abstract

A congenic strain of C3HSS mice, which is histocompatible with C3H mice but differs from them in susceptibility to mouse hepatitis virus (MHV), has been developed by introducing the gene for susceptibility to the MHV-PRI virus from the PRI mice. This was accomplished by continual back-crossing of the hybrids to the C3H mice, but at the same time by selection of susceptibility by use of macrophage culture tests. After 20 back-crosses, a strain homozygous for susceptibility was produced by brother-sister mating of individual mice whose potential for carrying the recessive gene for resistance was tested in progeny. Since the original choice of mice for breeding was based on in vitro macrophage susceptibility, and since highly susceptible mice were developed on the same basis, it seems evident that macrophage susceptibility is an integral aspect of mouse susceptibility. The continued production of almost 50% susceptible mice in the back-crosses is further evidence of the dominant one-locus explanation of genetic susceptibility to this agent. Incomplete penetrance may also be present in 8 and 9 week old mice of the C3HSS strain since there was a sharp decrease in susceptibility of these mice even though their macrophages in culture maintained full susceptibility.

Entities:  

Mesh:

Year:  1976        PMID: 135262     DOI: 10.3181/00379727-152-39426

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  17 in total

Review 1.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

2.  Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.

Authors:  G V Quinnan; J F Manischewitz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

3.  Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA.

Authors:  P Y Shi; W Li; M A Brinton
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.

Authors:  R K Williams; G S Jiang; S W Snyder; M F Frana; K V Holmes
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3.

Authors:  D G Brownstein; P N Bhatt; L Gras; T Budris
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Peritoneal macrophage alterations caused by naturally occurring mouse hepatitis virus.

Authors:  G A Boorman; M I Luster; J H Dean; M L Campbell; L A Lauer; F A Talley; R E Wilson; M J Collins
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

9.  Influences of nutrition on immunity and susceptibility to mouse hepatitis virus type 2.

Authors:  A H Esa; M Reissig
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

10.  Mutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59.

Authors:  D R Wessner; P C Shick; J H Lu; C B Cardellichio; S E Gagneten; N Beauchemin; K V Holmes; G S Dveksler
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.